Endoscopic Submucosal Dissection (Esd) for Colorectal Tumors

Saito, Yutaka; Sakamoto, Taku; Fukunaga, Shusei; Nakajima, Takeshi; Kuriyama, Shinsuke; Matsuda, Takahisa

doi:10.1111/j.1443-1661.2009.00870.x

Cited by 92 publications

(63 citation statements)

References 28 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[61][62][63][64] However, it is not widely available in the UK and the majority of evidence for ESD for NETs is from the rectal carcinoid literature. [65][66][67][68][69] Endoscopic resection of nonmetastatic localised lesions <2 cm with ≤6 lesions has been demonstrated to be as effective as surgical resection. For more advanced lesions >1 cm, with EUS-assessed involvement of the muscularis propria and/or local lymph nodes, surgical resection is indicated.…”

Section: Additional Investigationsmentioning

confidence: 99%

Review article: the investigation and management of gastric neuroendocrine tumours

Basuroy

Haji

Ramage

et al. 2014

Aliment Pharmacol Ther

128

View full text Add to dashboard Cite

Summary Background Gastric carcinoids (GCs) or neuroendocrine tumours (NETs) are increasingly identified at endoscopy, and account for 0.6–2% of all gastric polyps identified. The SEER database in the US has demonstrated a rising incidence of gastric NETs amongst all NETs; from 2.2% between 1950 and 1969 to 6.0% between 2000 and 2007. Aim To review the literature and assist clinicians in managing patients with GCs. Methods A literature search was conducted through MEDLINE using search terms: gastric, carcinoid, neuroendocrine tumour, therapy, endoscopy, mucosal resection, submucosal dissection. Relevant articles were identified through manual review. The reference lists of these articles were reviewed to include further appropriate articles. Results There are three types of GCs with important epidemiological, pathophysiological, histological and endoscopic differences that affect prognosis and management. Type 1 and 2 GCs develop in the context of hypergastrinaemia that originates from achlorhydria in atrophic gastritis and a gastrinoma, respectively. Type 3 GCs occur sporadically and independent of gastrin. The histological type, grade and Ki67 index are used to determine prognosis and direct clinical management. Type 1 GCs >1 cm in size and type 2 GCs should be assessed for invasion beyond the submucosa with EUS prior to endoscopic resection with EMR or ESD. Type 3 GCs should be managed as per recommendations for gastric adenocarcinoma. The treatment of advanced disease is multimodal. Conclusions Patients with gastric carcinoids should be discussed in a specialist neuroendocrine tumour multidisciplinary meeting to ensure all treatment options are explored in localised and advanced disease. Areas of controversy exist that need further research.

show abstract

Section: Additional Investigationsmentioning

confidence: 99%

Review article: the investigation and management of gastric neuroendocrine tumours

Basuroy

Haji

Ramage

et al. 2014

Aliment Pharmacol Ther

128

View full text Add to dashboard Cite

show abstract

“…69 Recently, an increasing number of colorectal ESDs have been reported from Japan showing the feasibility of the technique, especially in lateral spread tumors of the non-granular type. [70][71][72] Furthermore, a case series study of colorectal ESD, published by Niimi et al shows that the 5-year survival rate is as high as 95.3%. 73 Finally, a case report of ESD in the terminal ileum by Japanese endoscopists 74 shows the feasibility of this technique in this area.…”

Section: Endoscopic Submucosal Dissection For Lower Gastrointestinal mentioning

confidence: 99%

Endoscopic submucosal dissection

Robles-Medranda

2012

Gastroenterol Insights

View full text Add to dashboard Cite

Endoscopic submucosal dissection (ESD) is a minimally invasive technique developed by Japanese endoscopists that allows one-piece endoscopic removal of early malignant lesions in the gastrointestinal tract. There is now a large and ever-increasing number of reports worldwide, and in the West use of this technique is on the increase. New materials and techniques have been developed to improve the technical aspects of ESD. Recent reports show successful clinical outcomes and improved overall 5-year survival rates for this technique. This review aims to offer an update of ESD based on the latest reports in the literature.

show abstract

“…15,16 ESD offers a more complete en-bloc excision of larger, sessile polyps, typically >20 mm with a lower recurrence rate compared to EMR. 17 Although it is commonly used in the upper gastrointestinal tract, its use in the colon and rectum is more rare. TEM is technically challenging with a steep learning curve making it difficult for surgeons to adopt this technique over conventional TAE.…”

Section: Tes Compared To Other Local Proceduresmentioning

confidence: 99%

Transanal endoscopic surgery: patient selection and perspectives

Petrucci

Sands

2016

OAS

View full text Add to dashboard Cite

Abstract:Transanal endoscopic surgery is a 30-year innovation, which has allowed surgeons to treat patients with benign and early malignant rectal tumors using a minimally invasive approach. Its use in colorectal surgery continues to expand and be of interest for surgeons practicing in the minimally invasive surgical era. This review provides an overview of transanal endoscopic surgery, focusing on its different platforms, learning curve, and specific indications for benign and malignant diseases of the rectum. It reviews patient selection, with a focus on patient-and tumor-specific characteristics involved in the selection process, preparation for surgery, complications, and outcomes. Lastly, it reviews novel uses for transanal endoscopic surgery and future prospects.

show abstract

Endoscopic Submucosal Dissection (Esd) for Colorectal Tumors

Abstract: Endoscopic submucosal dissection is a feasible technique for treating large superficial colorectal tumors because it provides a higher en-bloc resection rate and is less invasive than surgical resection.

Cited by 92 publications

References 28 publications

Review article: the investigation and management of gastric neuroendocrine tumours

Review article: the investigation and management of gastric neuroendocrine tumours

Endoscopic submucosal dissection

Transanal endoscopic surgery: patient selection and perspectives

Contact Info

Product

Resources

About